Clinical Trials Sponsored by NeuroVasc Technologies
Total 1454 results
-
NeuroVasc TechnologiesRecruitingAcute Ischemic StrokeUnited States
-
Neovasc Inc.Active, not recruitingMitral Valve RegurgitationUnited States, Canada, Belgium
-
Neovasc Inc.CompletedRefractory AnginaUnited Kingdom, Canada, Belgium, Denmark, Netherlands, Sweden
-
Neovasc Inc.Active, not recruitingMitral Valve RegurgitationSpain, Italy, Germany, Israel, Netherlands, United Kingdom
-
Neovasc Inc.CompletedAngioplastyUnited States, Canada, Netherlands
-
Neurovance, Inc.CompletedHealthy Volunteers | Drug UsersUnited States
-
Neurovance, Inc.CompletedNormal, Healthy VolunteersAustralia
-
Neovasc Inc.Shockwave Medical, Inc.RecruitingRefractory AnginaUnited States, Canada
-
Neovasc Inc.Shockwave Medical, Inc.Active, not recruitingAngina Pectoris | Chronic Stable Angina | Angina Pectoris, StableNetherlands, Spain, United Kingdom, Germany, Italy, Switzerland, Belgium, France, Austria
-
BioStem TechnologiesNot yet recruitingDiabetic Foot Ulcer
-
Calyan TechnologiesNot yet recruitingBradycardia | Ventricular Pacing With Rate ResponseUnited States
-
DBV TechnologiesRecruitingAllergy, PeanutUnited States, Canada, France, Germany, Ireland, Netherlands, Spain, United Kingdom, Australia
-
Archean TechnologiesRecruitingSpeech Intelligibility in NoiseFrance
-
Paragonix TechnologiesEnrolling by invitationLiver Diseases | Liver Transplant Disorder | Liver Dysfunction | Liver Transplant RejectionUnited States
-
Allurion TechnologiesActive, not recruitingObesityUnited States
-
Revibe TechnologiesCompleted
-
DBV TechnologiesEnrolling by invitationPeanut AllergyUnited States
-
Neosense TechnologiesTerminatedNewborn, Infant, Disease | Oxygen Saturation | CathetersSweden
-
DBV TechnologiesCompletedPeanut AllergyUnited States, Netherlands, France, Canada, Poland
-
Nemechek TechnologiesCompletedSevere Acute Respiratory Syndrome Coronavirus 2Argentina
-
DBV TechnologiesCompletedFood AllergyUnited States, Canada
-
DBV TechnologiesCompleted
-
Micell TechnologiesCompletedFirst-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-I)Coronary Artery DiseaseBelgium, Australia, New Zealand
-
Allurion TechnologiesUnknownObesity | OverweightCzech Republic, Greece
-
Harvest TechnologiesCompletedCritical Limb IschemiaUnited States
-
AVAX TechnologiesUnknown
-
Flashback TechnologiesCompletedHemorrhageUnited States
-
Harvest TechnologiesCompletedCongestive Heart FailureGermany, India, Peru
-
Zetiq TechnologiesUnknownEvaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyBladder Cancer Transitional Cell CarcinomaIsrael
-
DBV TechnologiesCompletedPeanut AllergyUnited States
-
Momelan TechnologiesUnknownNeoplasm of SkinUnited States
-
Ventor TechnologiesUnknownAortic Valve DiseaseGermany
-
FoxHollow TechnologiesTerminatedPeripheral Vascular DiseasesUnited States
-
Genelabs TechnologiesUnknown
-
Bloom TechnologiesRecruitingFetal MonitoringBelgium
-
Reliev TechnologiesNot yet recruitingFocal Epilepsy | Epilepsy; Seizure
-
MediCool TechnologiesNot yet recruiting
-
DBV TechnologiesRecruitingCow's Milk AllergyItaly, United States, Lithuania, Canada
-
Stimwave TechnologiesNot yet recruiting
-
Paragonix TechnologiesEnrolling by invitationEmphysema | Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Cystic Fibrosis | Interstitial Lung Disease | COPDUnited States, Belgium
-
Paragonix TechnologiesEnrolling by invitationHeart Diseases | Heart Failure | Heart Defects, CongenitalUnited States, Spain, Austria, United Kingdom
-
Bloom TechnologiesCompleted
-
Cardiologs TechnologiesCompletedAtrial FibrillationUnited States
-
Bloom TechnologiesCompleted
-
Alung TechnologiesTerminatedAcute Exacerbation of COPDUnited States
-
DBV TechnologiesCompletedPeanut AllergyUnited States, Netherlands, France, Canada